1. Home
  2. Labeler Index
  3. Pfizer Laboratories Div Pfizer Inc
  4. 0069-2465
  5. NDC Package Code: 0069-2465-10 Abrysvo

NDC Package 0069-2465-10 Abrysvo

Respiratory Syncytial Virus Vaccine Injection, Powder, Lyophilized, For Solution - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-2465-10
Package Description:
10 VIAL in 1 CARTON / .5 mL in 1 VIAL (0069-2465-19)
Product Code:
0069-2465
Proprietary Name:
Abrysvo
Non-Proprietary Name:
Respiratory Syncytial Virus Vaccine
Substance Name:
Recombinant Stabilized Rsv A Prefusion F Antigen; Recombinant Stabilized Rsv B Prefusion F Antigen
Usage Information:
ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.
11-Digit NDC Billing Format:
00069246510
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2642142 - respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized 60 MCG / respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized 60 MCG in 0.5 ML Injection
  • RxCUI: 2642142 - 0.5 ML respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized 0.12 MG/ML / respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized 0.12 MG/ML Injection
  • RxCUI: 2642142 - respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized 60 MCG / respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized 60 MCG per 0.5 ML Injection
  • RxCUI: 2642148 - ABRYSVO 60 MCG / 60 MCG in 0.5 ML Injection
  • RxCUI: 2642148 - 0.5 ML respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized 0.12 MG/ML / respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized 0.12 MG/ML Injection [Abrysvo]
Product Type:
Vaccine
Labeler Name:
Pfizer Laboratories Div Pfizer Inc
Dosage Form:
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route(s):
Intramuscular - Administration within a muscle.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
BLA125769
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
07-30-2024
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
0069-2465-011 VIAL in 1 CARTON / .5 mL in 1 VIAL (0069-2465-19)

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0069-2465-10?

The NDC Packaged Code 0069-2465-10 is assigned to a package of 10 vial in 1 carton / .5 ml in 1 vial (0069-2465-19) of Abrysvo, a vaccine label labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intramuscular form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

Is NDC 0069-2465 included in the NDC Directory?

Yes, Abrysvo with product code 0069-2465 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on July 30, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0069-2465-10?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

What is the 11-digit format for NDC 0069-2465-10?

The 11-digit format is 00069246510. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20069-2465-105-4-200069-2465-10